BH
Highly rated in
12
conditions

Dr. Brian J. Heller

Mobile Office
Mobile, AL
Highly rated in
12
conditions
Specialties:Oncology | Hematology Oncology
Experience:26 Years
Clinical Trials:Currently Recruiting for 2 Trials
Accepts:New PatientsMedicare
Highly rated in
12
conditions
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Brian J. Heller's experience treating your condition:
About Dr. Brian J. Heller

Brian Heller is an Oncologist and a Hematologist Oncology expert in Mobile, Alabama. Heller has been practicing medicine for over 26 years and is highly rated in 12 conditions, according to our data. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, and Stomach Cancer. He is licensed to treat patients in Louisiana and Alabama. Heller is currently accepting new patients.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 8 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Brian J. Heller it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Brian J. Heller accepts the following insurance:

  •  Blue Cross Blue Shield
  •  Ambetter
  •  UnitedHealthcare
  •  Magnolia Health
Call to see if your plan is accepted.
Locations
3 Mobile Infirmary Cir, Suite 302, Mobile, AL 36607
Other Locations
1851 N Mckenzie St, Suite 103, Foley, AL 36535
29653 Anchor Cross Blvd, Daphne, AL 36526
188 Hospital Dr, Fairhope, AL 36532
3719 Dauphin St, Mobile, AL 36608
Background & Education
Graduate Institution
Louisiana State University School Of Medicine In New Orleans, 1997
Specialties
Oncology
Hematology Oncology
Licenses
Internal Medicine in LA
Hospital Affiliations
Ascension Providence Hospital - Southfield Campus
South Baldwin Regional Medical Center
Springhill Medical Center
Thomas Hospital
Providence Hospital
Mobile Infirmary
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Enrollment Status: Recruiting
Publish Date: December 14, 2022
Intervention Type: Other, Drug, Biological
Study Phase: Not Applicable
A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Enrollment Status: Recruiting
Publish Date: December 02, 2022
Intervention Type: Other, Drug
Study Drug: Crizotinib
Study Phase: Phase 3
Randomized Study of Erlotinib vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Active, not recruiting
Publish Date: October 19, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL) - A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers
Enrollment Status: Active, not recruiting
Publish Date: September 26, 2022
Intervention Type: Biological
Study Drug: Nivolumab
Study Phase: Phase 3
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
Enrollment Status: Active, not recruiting
Publish Date: August 03, 2022
Intervention Type: Radiation, Procedure
Study Phase: Phase 3
A Randomized, Open Label, Phase III Trial to Evaluate the Efficacy and Safety of Palbociclib + Anti-HER2 Therapy + Endocrine Therapy vs. Anti-HER2 Therapy + Endocrine Therapy After Induction Treatment for Hormone Receptor Positive (HR+)/HER2-Positive Metastatic Breast Cancer
Enrollment Status: Active, not recruiting
Publish Date: March 18, 2022
Intervention Type: Drug
Study Drugs: PalbociclibTrastuzumabPertuzumabLetrozoleAnastrozoleExemestaneFulvestrant
Study Phase: Phase 3
A Phase II/III Trial of Neoadjuvant FOLFOX With Selective Use of Combined Modality Chemoradiation Versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection With Total Mesorectal Excision (PROSPECT)
Enrollment Status: Active, not recruiting
Publish Date: October 19, 2021
Intervention Type: Drug, Procedure, Other
Study Phase: Phase 2/Phase 3
A Randomized Phase II Trial of Tamoxifen Versus Z-Endoxifen HCL in Postmenopausal Women With Metastatic Estrogen Receptor Positive, HER2 Negative Breast Cancer
Enrollment Status: Active, not recruiting
Publish Date: September 28, 2021
Intervention Type: Other, Drug
Study Drugs: Endoxifen HydrochlorideTamoxifen Citrate
Study Phase: Phase 2
View 6 Less Clinical Trials -
1 Total Publications
Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher-risk myelodysplastic syndromes.
Journal: Cancer
Published: August 31, 2016
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
DC
Dr. Daniel G. Cameron
Oncology | Hematology Oncology
Highly rated in
59
conditions
Oncology
Hematology Oncology

Infirmary Health System

Mitchell Cancer Institute

1660 Spring Hill Ave, 
Mobile, AL 
 0.1 mi

Daniel Cameron is an Oncologist and a Hematologist Oncology expert in Mobile, Alabama. Cameron has been practicing medicine for over 25 years and is highly rated in 59 conditions, according to our data. His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Colorectal Cancer, Familial Colorectal Cancer, and Bone Marrow Aspiration. He is licensed to treat patients in Alabama. Cameron is currently accepting new patients.

BP
Dr. Brian E. Persing
Hematology Oncology | Oncology
Highly rated in
40
conditions
Hematology Oncology
Oncology

Singing River Health System

Mitchell Cancer Institute

1660 Spring Hill Ave, 
Mobile, AL 
 0.1 mi

Brian Persing is a Hematologist Oncology specialist and an Oncologist in Mobile, Alabama. Persing has been practicing medicine for over 21 years and is highly rated in 40 conditions, according to our data. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Lymphocytic Lymphoma (SLL), and Familial Wilms Tumor 2. He is licensed to treat patients in Mississippi and Alabama. Persing is currently accepting new patients.

TB
Dr. Thaddeus A. Beeker
Oncology | Hematology Oncology
Highly rated in
13
conditions
Oncology
Hematology Oncology

Infirmary Health System

Diagnostic & Medical Clinic

1700 Spring Hill Ave, 
Mobile, AL 
 0.2 mi

Thaddeus Beeker is an Oncologist and a Hematologist Oncology expert in Mobile, Alabama. Beeker has been practicing medicine for over 34 years and is highly rated in 13 conditions, according to our data. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Smoldering Multiple Myeloma, Bone Marrow Aspiration, and Colonoscopy. He is licensed to treat patients in Alabama. Beeker is currently accepting new patients.